Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
1.000 |
10 |
|
1998 |
2014 |
Acute leukemia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
639
|
50
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2016 |
Acute biphenotypic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
45
|
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2007 |
Mixed phenotype acute leukemia
|
disease |
|
Neoplastic Process
|
37
|
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2007 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.060 |
None |
1.000 |
6 |
|
2000 |
2014 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.050 |
None |
1.000 |
5 |
|
2000 |
2014 |
Hypothyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
613
|
283
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Noninfiltrating Intraductal Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
486
|
13
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.380 |
None |
0.875 |
8 |
|
2002 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.080 |
None |
0.875 |
8 |
|
2002 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.310 |
None |
1.000 |
2 |
|
2002 |
2004 |
Leukemogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
996
|
25
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2014 |
Childhood Acute Myelomonocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
3
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Adult Acute Myelomonocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
3
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Acute myelomonocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
105
|
3
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.905 |
21 |
|
2004 |
2020 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2018 |
Maturation defect
|
phenotype |
|
Acquired Abnormality
|
43
|
2
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Androgen-Insensitivity Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
247
|
176
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2013 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.320 |
None |
1.000 |
3 |
|
2007 |
2011 |
Childhood Acute Myeloid Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
215
|
6
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Glucocorticoid Receptor Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
104
|
12
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Histiocytosis haematophagic
|
disease |
|
Disease or Syndrome
|
36
|
2
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |